The Forum on Cardiovascular Disease in Women, which took place on Friday, April 20 and Saturday, April 21, was a success with over a hundred medical professionals, most of whom were specialists, taking part.
The aim of the meeting was to analyze the various differences in women that help identify patients at greater risk of suffering heart disease to be able to provide them with the latest treatment strategies based on scientific evidence.
Cardiovascular Disease in Women
In Spain, cardiovascular disease is the primary cause of death among women, as is the case in the rest of the western world. In spite of the weight of that information, women still consider it “a man’s disease”.
In clinical practice, a steady increase in the incidence of cardiovascular disease in females is observed and there are specific differences in cardiovascular diseases when they appear in women, which may influence the diagnosis and therapeutic approach to the disease.
The conference began with the opening ceremony, at the hands of Dr Pedro Luis Cobiella, President of the Hospiten Group and of the Forum Director, Dr Antonio Ramirez, Head of the Cardiology Service at Hospiten Estepona.
During the conference, Cardiovascular Disease was discussed in depth, covering subjects like risk factors of cardiovascular disease, heart failure, non-coronary vascular diseases, arrhythmia and ischemic cardiopathy – all of this focused on females and discussing strategies in accordance with the differential aspects.
At the same time, cardiovascular diseases in women were dealt with from the approach of different specialties, like Interventional Radiology, Internal Medicine, Gynecology and Neurology, which gave the forum an essentially multidisciplinary character.
Some of the most relevant presentations were those of Professor Dr Suarez de Lezo, Professor in Cardiology and Head of the Reina Sofia Hospital Cardiology Service in Cordoba, and of Dr Rafael Llorens, Head of the Hospiten Cardiac Surgery Service.
Dr Llorens dealt with the subject of coronary surgery from different scientific points of view and Dr Suarez de Lezo closed the forum talking about his experience in the percutaneous treatment of degenerative aortic stenosis, a condition that impedes free blood flow from the left ventricle to the aorta.
The closure of the event was carried out by Dr Antonio Ramirez and Dr Juan Antonio Siles, directors and cornerstones of the forum, who thanked the attendees for their attendance and agreed that “the debate that came out of the forum would improve the quality of health care for patients affected”.
The Hospiten Group is an international healthcare network committed to providing top quality service, with over 40 years’ experience and sixteen private medical-hospital centers in Spain, the Dominican Republic, Mexico and Jamaica, and more than a hundred health centers, privately owned and associated, under the brand name Clinic Assist, and which attends over a 1.000.000 patients a year from all over the world.